Content area
Full Text
[Image omitted] - (http://www.fiercebiotech.com/story/want-start-biotech-buyout-rumor-start-company-juno/2015-06-04)
AstraZeneca CEO Pascal Soriot
Anyone looking for an example of just how easy it is to start a biotech buyout rumor these days need look no further than Bloomberg's report on AstraZeneca's ($AZN) Pascal Soriot earlier in the week.
With the big ASCO meeting beginning to wind down, Bloomberg caught up with the acquisitive CEO and came away with a story that a CAR-T company such as Juno ($JUNO) could prove quite appealing to AstraZeneca, which has its own cutting-edge immuno-oncology therapy to boast of. Bloomberg quickly amended the report to say that it was CAR-T companies in general that Soriot was referring to, with Reuters adding a comment from...